Reports of increased JNK phosphorylation in PTX-treated cancer cells [70] and in BTZ-treated rodent DRG [71–73] lean towards the notion that the ameliorative effects of SP600125 on iPSC-DSN treated with cytotoxic drugs are due to JNK. The gene discussed is MAPK8; the disease is cancer.